**Closure of my websites askdrray.com and nethealthbook.com**

These websites will be taken down on **April 30, 2025** and no further updates will be provided.
I hope you enjoyed the content of these websites. You can continue to read Dr. Schilling’s blogs which I publish daily on Quora

My home page there is: ** https://www.quora.com/profile/Ray-Schilling**

Click on this: Under my image there is a heading “Profile”. Right underneath this you find a search box entitled “search content”. Type in any term you are interested in. You will get several answers I have written (I have written more than 15,000 answers).

On Quora you can also write comments that I will answer.

Thank you for your trust in the past. Ray Schilling, MD
**Closure of my websites askdrray.com and nethealthbook.com**

These websites will be taken down on **April 30, 2025** and no further updates will be provided.
I hope you enjoyed the content of these websites. You can continue to read Dr. Schilling’s blogs which I publish daily on Quora

My home page there is: ** https://www.quora.com/profile/Ray-Schilling**

Click on this: Under my image there is a heading “Profile”. Right underneath this you find a search box entitled “search content”. Type in any term you are interested in. You will get several answers I have written (I have written more than 15,000 answers).

On Quora you can also write comments that I will answer.

Thank you for your trust in the past. Ray Schilling, MD
Your Online Health Information Site

Advertisement

Ehrlichiosis

Introduction

Small rickettsia-like bacteria cause this infection that can only multiply inside two special white blood cell types, namely monocytes and granulocytes.

In the cycle of infection brown dog ticks are function as carriers, although we do not yet fully know where the main reservoir for the Ehrlichia species is. The medical literature describes two types:

  • Ehrlichia chaffeensis , which multiplies specifically in monocytes in the human host and causes human monocytic ehrlichiosis (HME).
  • The other type is Ehrlichia phagocytophilia, which multiplies in granulocytes (=pus cells) and is the cause of human granulocytic ehrlichiosis (HGE). These two types are found in the US with HME being more common in southern states, whereas HGE has been found more in the upper midwestern and northeastern states. There is another variety of ehrlichiosis, which is found in Japan and goes under the name Sennetsu fever.

Signs and symptoms

The American ehrlichiosis is a non specific flu-like illness, which starts 1 to 3 weeks after a tick bite with fever, lack of appetite, muscle aches, headaches, nausea and vomiting. Occasionally the onset is more abrupt and symptoms more acute. In the more acute form a life threatening condition, called disseminated intravascular coagulation (DIC), is developing.

This leads to lack of clotting, a loss of platelets and possible shock and death, if not recognized early and treated successfully. Liver function can also be affected and deteriorates, if the disease is more severe.

Diagnostic tests

The clinical history of tick bites followed by the signs and symptoms mentioned above, suggests the diagnosis clinically.

Blood tests are then done to confirm or rule out the disease. Low platelet counts (thrombocytopenia), low white blood count (leukopenia) and elevated liver enzymes( transaminases) in this setting point to this diagnosis. The specific tests are either a serological test specific for ehrlichiosis showing the bacterium in the monocyte (see arrow) or a genetic test involving a polymerase chain reaction, which allows earlier diagnosis of this disease before DIC sets in.

 Ehrlichiosis (Tick, But No Bite Yet)

Ehrlichiosis (Tick, But No Bite Yet)

Treatment

Treatment is given based on the clinical presumptive diagnosis, as early treatment will quickly eradicate the disease and prevent complications such as DIC, shock and death. Tetracycline or doxycycline is the treatment of choice except for pregnant women, where chloramphenicol is the accepted alternative. There is a small risk of agranulocytosis from chloramphenicol, but most physicians agree that the risk of not treating the ehrlichiosis is greater than the risk of agranulocytosis.

References

1.The Merck Manual, 7th edition, by M. H. Beers et al., Whitehouse Station, N.J., 1999. Chapter 265.

2.James Chin et al., Editors: Control of Communicable Diseases Manual, 17th edition, 2000, American Public Health Association

3.The Merck Manual, 7th edition, by M. H. Beers et al., Whitehouse Station, N.J., 1999. Chapter 112.

4. The Merck Manual, 7th edition, by M. H. Beers et al., Whitehouse Station, N.J., 1999. Chapter 115.

5. The Merck Manual, 7th edition, by M. H. Beers et al., Whitehouse Station, N.J., 1999. Chapter 113.

Last modified: April 9, 2021

Disclaimer
This outline is only a teaching aid to patients and should stimulate you to ask the right questions when seeing your doctor. However, the responsibility of treatment stays in the hands of your doctor and you.